(BIVI) Biovie - Performance -77.5% in 12m
Compare BIVI with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-88.60%
#170 in Group
Rel. Strength
4.31%
#7614 in Universe
Total Return 12m
-77.48%
#154 in Group
Total Return 5y
-97.20%
#161 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -
(?) Percentile in Group
12m Total Return: BIVI (-77.5%) vs XBI (-14%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
2.95% | 13.3% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
12.6% | 32.2% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-8.67% | -12.4% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
15.8% | 12% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
4.68% | 18.2% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
14.1% | 27.3% | -5.64% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
21.4% | -17.2% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
22.4% | 0.59% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: BIVI vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for BIVI
Total Return (including Dividends) | BIVI | XBI | S&P 500 |
---|---|---|---|
1 Month | 41.24% | 2.02% | 2.87% |
3 Months | -39.78% | -15.44% | -6.42% |
12 Months | -77.48% | -14.02% | 9.87% |
5 Years | -97.20% | -26.47% | 107.51% |
Trend Score (consistency of price movement) | BIVI | XBI | S&P 500 |
1 Month | 76.9% | 57% | 89.4% |
3 Months | -69.3% | -82.3% | -72% |
12 Months | -86.6% | -53.1% | 49.3% |
5 Years | -86.2% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #20 | 38.4% | 37.3% |
3 Month | #123 | -28.8% | -35.7% |
12 Month | #153 | -73.8% | -79.5% |
5 Years | #162 | -96.2% | -98.7% |
FAQs
Does BIVI Biovie outperforms the market?
No,
over the last 12 months BIVI made -77.48%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.02%.
Over the last 3 months BIVI made -39.78%, while XBI made -15.44%.
Over the last 3 months BIVI made -39.78%, while XBI made -15.44%.
Performance Comparison BIVI vs Indeces and Sectors
BIVI vs. Indices BIVI is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -7.01% | 38.4% | -57.4% | -87.4% |
US NASDAQ 100 | QQQ | -7.26% | 36.5% | -57.8% | -88.8% |
US Dow Jones Industrial 30 | DIA | -7.29% | 39.6% | -56.4% | -83.9% |
German DAX 40 | DAX | -9.13% | 22.0% | -83.0% | -103% |
Shanghai Shenzhen CSI 300 | CSI 300 | -7.67% | 35.0% | -56.6% | -83.1% |
Hongkong Hang Seng | HSI | -10.5% | 25.0% | -66.9% | -89.6% |
India NIFTY 50 | INDA | -4.62% | 39.0% | -59.3% | -79.8% |
Brasil Bovespa | EWZ | -9.06% | 29.7% | -66.6% | -71.0% |
BIVI vs. Sectors BIVI is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -7.19% | 37.6% | -63.6% | -97.8% |
Consumer Discretionary | XLY | -7.93% | 37.7% | -55.2% | -91.5% |
Consumer Staples | XLP | -6.64% | 39.2% | -64.3% | -85.0% |
Energy | XLE | -7.99% | 41.2% | -51.4% | -67.7% |
Financial | XLF | -7.64% | 35.7% | -63.3% | -99.0% |
Health Care | XLV | -3.22% | 45.6% | -52.2% | -71.6% |
Industrial | XLI | -8.58% | 33.9% | -58.4% | -87.5% |
Materials | XLB | -7.0% | 36.5% | -53.3% | -71.5% |
Real Estate | XLRE | -6.68% | 35.1% | -59.8% | -90.9% |
Technology | XLK | -7.90% | 34.5% | -55.1% | -84.5% |
Utilities | XLU | -8.05% | 35.6% | -65.2% | -93.4% |
Aerospace & Defense | XAR | -7.52% | 31.9% | -66.7% | -103% |
Biotech | XBI | 1.07% | 39.2% | -36.3% | -63.5% |
Homebuilder | XHB | -6.57% | 38.2% | -43.8% | -67.7% |
Retail | XRT | -7.16% | 37.7% | -51.1% | -73.2% |